These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15699067)

  • 1. Bacterial toxins and the immune system: show me the in vivo targets.
    Galán JE
    J Exp Med; 2005 Feb; 201(3):321-3. PubMed ID: 15699067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthrax toxins: A paradigm of bacterial immune suppression.
    Baldari CT; Tonello F; Paccani SR; Montecucco C
    Trends Immunol; 2006 Sep; 27(9):434-40. PubMed ID: 16861036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel superantigenic exotoxin from Yersinia psuedotuberculosis and its position in the classification of the entire bacterial toxins.
    Uchiyama T
    Contrib Microbiol Immunol; 1995; 13():191-4. PubMed ID: 8833831
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
    Xu L; Frucht DM
    Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
    Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax toxin evades Toll-like receptor recognition, whereas its cell wall components trigger activation via TLR2/6 heterodimers.
    Triantafilou M; Uddin A; Maher S; Charalambous N; Hamm TS; Alsumaiti A; Triantafilou K
    Cell Microbiol; 2007 Dec; 9(12):2880-92. PubMed ID: 17651447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
    Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
    Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling.
    Rossi Paccani S; Tonello F; Patrussi L; Capitani N; Simonato M; Montecucco C; Baldari CT
    Cell Microbiol; 2007 Apr; 9(4):924-9. PubMed ID: 17087730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical functions of Yersinia type III effectors.
    Shao F
    Curr Opin Microbiol; 2008 Feb; 11(1):21-9. PubMed ID: 18299249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of dendritic cell differentiation and function by YopJ of Yersinia pestis.
    Lindner I; Torruellas-Garcia J; Kolonias D; Carlson LM; Tolba KA; Plano GV; Lee KP
    Eur J Immunol; 2007 Sep; 37(9):2450-62. PubMed ID: 17705129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the ability of N-terminal fragment of lethal factor of Bacillus anthracis for delivery of Mycobacterium T cell antigen ESAT-6 into cytosol of antigen presenting cells to elicit effective cytotoxic T lymphocyte response.
    Chandra S; Kaur M; Midha S; Bhatnagar R; Banerjee-Bhatnagar N
    Biochem Biophys Res Commun; 2006 Dec; 351(3):702-7. PubMed ID: 17084814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
    Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
    Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of the Yersinia effector proteins in inhibiting host immune responses.
    Navarro L; Alto NM; Dixon JE
    Curr Opin Microbiol; 2005 Feb; 8(1):21-7. PubMed ID: 15694853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anthrax revisited: Bacillus anthracis toxins as novel actors of immune escape?].
    Tournier JN; Quesnel-Hellmann A; Cleret A; Mathieu J; Goossens PL; Mock M; Vidal DR
    Bull Acad Natl Med; 2006 Jan; 190(1):155-63; discussion 163-7. PubMed ID: 16878452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection.
    Cleret A; Quesnel-Hellmann A; Mathieu J; Vidal D; Tournier JN
    J Infect Dis; 2006 Jul; 194(1):86-94. PubMed ID: 16741886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.